Zhou C, Liu S. Evaluation of the efficacy of MST-312, as a telomerase inhibitor, in the treatment of patients with multiple myeloma after stem cell transplantation. Cell Mol Biol (Noisy-le-grand) [Internet]. 2022 Jan. 2 [cited 2024 Nov. 21];67(4):115-20. Available from: https://mail.cellmolbiol.org/index.php/CMB/article/view/4043